Cardinal Health Expands At-Home Solutions with Two Acquisitions
Jul 20, 2026, 4:47 PM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
The deals are small relative to CAH; however, they expand a high-growth, cash-flow-positive segment, with explicit EPS accretion guidance within 12 months, suggesting a favorable re-rating if closing proceeds smoothly and integration milestones are met.
AI summary
What happened, with direct paths to the underlying reporting
Cardinal Health announced two tuck-in acquisitions to broaden its at-Home Solutions platform, purchasing AdaptHealth's Diabetes Health business and Strive Medical for about $360 million in cash. The deals extend diabetes and urology capabilities, building on the ADS integration progress and the ContinuCare Pathway program. Management expects the acquisitions to be EPS-accretive within the first year after close, signaling meaningful near-term margin and growth benefits if closing proceeds smoothly.
Cardinal Health to acquire AdaptHealth's Diabetes Health business; expands diabetes care footprint.
Also acquiring Strive Medical for urology and other home-care supplies; total cash about $360 million.
Combined deal value around $360M cash; accretive to non-GAAP EPS within 12 months.
Regulatory approvals required; closing conditions may affect timing.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event
Cardinal Health posted a mixed Q4, with revenue up 6% and profits helped by a one-time tariff refund. The company issued fiscal 2027 EPS guidance above consensus, driven by solid…
Cardinal Health has increased its profit forecast for 2026, citing strong demand for specialty and branded medicines in its pharmaceuticals division. This positive outlook indicat…
Cardinal Health reported strong fiscal second-quarter results, with a 19% revenue increase to $65.6 billion and an elevated non-GAAP EPS guidance of $10.15-$10.35 for FY 2026, fue…